Kathleen Collins is the founder of Addition Therapeutics. Addition Therapeutics has raised $100M in total funding. Based in South San Francisco, CA.
Kathleen Collins is a Professor and former Head of the Division of Biochemistry, Biophysics, and Structural Biology at the University of California, Berkeley, holding the Walter and Ruth Schubert Family Chair. She is the founder of Addition Therapeutics, a company leveraging her foundational technology in retrotransposase expertise to develop RNA-only therapeutics for chronic and rare diseases. Addition Therapeutics has raised $100 million in funding.
Full founder directory · Investor directory · Company funding database · Fundraising library